Skip to content
Open access

Derivation of a new induced pluripotent stem cell line ORIONi004-A for modelling Duchenne muscular dystrophy.

Aug 2026 · Stem Cell Research · Vol 95, pp. 104077 · 0 citations · 4 references
Medicine

TL;DR

Peripheral blood was used as source for primary cells and subsequently reprogrammed into induced pluripotent stem cells with synthetic Sendai vector, which showed the expression of pluripotency factors and the ability to differentiate into all three germ layers.

Abstract

Anew in vitromodel for modeling Duchenne muscular dystrophy, derived from pediatric patient with a unique mutation in DMD gene is introduced. Peripheral blood was used as asource for primary cells (mononuclear cells) and subsequently reprogrammed into induced pluripotent stem cells with synthetic Sendai vector. Reprogrammed iPS cells showed the expression of pluripotency factors and the ability to differentiateinto all three germ layers.

Read PDF

Similar papers

Open access Aug 2026

Generation of two induced pluripotent stem cell lines from Marfan syndrome patients carrying FBN1 mutations

Induced pluripotent stem cell lines derived from two Marfan syndrome patients with mutations in the FBN1 gene exhibited typical iPSC morphology, normal karyotype, undifferentiated states, and trilineage differentiation capacity.

Byron W H Mui, M. Chorsi, Christopher D. Yan et al. · 1 citation
Open access Sep 2026

Establishment of a human induced pluripotent stem cell line, KMUGMCi011-A, from a patient bearing a frameshift mutation in the KMT2D gene leading Kabuki syndrome 1.

The peripheral blood mononuclear cells from a patient carrying frameshift mutation in the KMT2D gene were reprogrammed using the CytoTune-iPS2.0 Sendai Reprogramming Kit to allow proper in vitro disease modelling of Kabuki syndrome 1.

Hiroki Ura, Takako Hiyoshi, Y. Niida · 0 citations
Open access Aug 2026

Generation and characterization of a patient-specific human induced pluripotent stem cell line from a Skogholt syndrome patient (ASCFi003-A)

This patient-specific iPSC line provides a valuable resource for generating choroid plexus organoids and neurons to investigate disease mechanisms and develop therapeutic strategies to investigate disease mechanisms and develop therapeutic strategies.

Weronika Przybala, Swapnil Gupta, H. Fjerdingstad et al. · 0 citations
Open access Oct 2026

Generation of human induced pluripotent stem cell line (CMCi015-A) from a patient with nephronophthisis harboring compound heterozygous loss-of-function variants in the NPHP4 gene.

Nephronophthisis, an autosomal recessive ciliopathy, is a rare genetic kidney disorder characterized by progressive tubulointerstitial fibrosis, corticomedullary cyst formation, and progression to end-stage renal disease. Here, we established a human induced pluripotent stem cell (hiPSC) line from peripheral blood mono...

Jeeyoung Yoon, Y. Shin, Han-Bi Lee et al. · 0 citations
Open access Aug 2026

Generation and characterization of two iPSC lines INDBi002-A and INDBi002-B from human keratinocytes of a healthy female using Sendai Virus reprogramming.

We established two fully characterized induced pluripotent stem cell (iPSC) lines from human keratinocytes via Sendai virus-mediated reprogramming. This non-integrating approach maintains genomic integrity, facilitating the generation of pluripotent cell lines with stable self-renewal and multilineage differentiation p...

Denise Sperlich, Katharina Becker, S. Klingenstein et al. · 0 citations
Open access Sep 2026

Generation of the induced pluripotent stem cell line SHUTCMi001-A from a patient with double primary lung and colon cancers.

Patients with synchronous multiple primary malignancies often exhibit unique genetic susceptibility. Here, we generated the induced pluripotent stem cell (iPSC) line, SHUTCMi001-A, from a 70-year-old patient with double primary lung squamous cell carcinoma and sigmoid colon adenocarcinoma with wild-type driver genes. T...

Jing-Yi Wei, Guan-Jin Wu, Chen-Bing Sun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.